Hedge Fund - Aquilo Capital Management
Arrowhead Pharmaceuticals Inc. (ARWR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $27,799,304 | 17.32% | 908,474 | $26.56 |
| 2 | 2023 - Q3 (2023-09-30) | $24,410,696 | 22.12% | 908,474 | $30.63 |
| 3 | 2023 - Q2 (2023-06-30) | $30,613,183 | 16.96% | 858,474 | $34.48 |
| 4 | 2023 - Q1 (2023-03-31) | $25,869,240 | 10.72% | 1,018,474 | $31.45 |
| 5 | 2022 - Q4 (2022-12-31) | $44,758,568 | 16.81% | 1,103,515 | $33.13 |
| 6 | 2022 - Q3 (2022-09-30) | $40,272,000 | 14.51% | 1,218,515 | $40.36 |
| 7 | 2022 - Q2 (2022-06-30) | $42,200,000 | 14.4% | 1,198,515 | $37.62 |
| 8 | 2022 - Q1 (2022-03-31) | $48,172,000 | 7.07% | 1,047,440 | $49.51 |
| 9 | 2021 - Q4 (2021-12-31) | $46,438,000 | 5.26% | 700,426 | $68.71 |
| 10 | 2021 - Q3 (2021-09-30) | $32,958,000 | 5.98% | 527,926 | $64.75 |
| 11 | 2021 - Q2 (2021-06-30) | $35,855,000 | 9.31% | 432,926 | $74.45 |
| 12 | 2021 - Q1 (2021-03-31) | $27,050,000 | 4.88% | 407,926 | $77.59 |
| 13 | 2020 - Q4 (2020-12-31) | $28,078,000 | 5.83% | 365,926 | $63.95 |
| 14 | 2020 - Q3 (2020-09-30) | $22,538,000 | 2.38% | 523,415 | $43.15 |
| 15 | 2020 - Q2 (2020-06-30) | $24,329,000 | 4.9% | 563,291 | $35.29 |
| 16 | 2020 - Q1 (2020-03-31) | $12,559,000 | 4.89% | 436,514 | $40.33 |
| 17 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $29.59 |
| 18 | 2019 - Q2 (2019-06-30) | $14,773,000 | 5.12% | 557,455 | $21.95 |
| 19 | 2019 - Q1 (2019-03-31) | $18,028,000 | 7.97% | 982,455 | $16.50 |
| 20 | 2018 - Q4 (2018-12-31) | $13,226,000 | 6.4% | 1,064,928 | $13.67 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:10.0000 on 2011-11-17